United States · 
Who invested in Timberlyne Therapeutics?
Timberlyne Therapeutics's investors include Venrock, Lilly Asia Ventures and Bain Capital Life Sciences.
United States · Series A startup
Who invested in Timberlyne Therapeutics
Funding summaryUpdated 26 Oct 2026
$180Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $180MJan 2025
- Investors
- 3
The rounds
- Jan 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Timberlyne Therapeutics
How much has Timberlyne Therapeutics raised?
Timberlyne Therapeutics has raised $180M across 1 round since 2025.
When did Timberlyne Therapeutics last raise?
Timberlyne Therapeutics's most recent round was a Series A of $180M in Jan 2025.
What was Timberlyne Therapeutics's biggest round?
Its most recent round, $180M in Jan 2025, is also its largest on record.
Who backed Timberlyne Therapeutics first?
Timberlyne Therapeutics's first round on record, in Jan 2025, was backed by Venrock, Lilly Asia Ventures and Bain Capital Life Sciences.
What stage is Timberlyne Therapeutics at?
Timberlyne Therapeutics's latest named round is a Series A, in Jan 2025.
Where is Timberlyne Therapeutics based?
Timberlyne Therapeutics is based in the United States.
Companies like Timberlyne Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.